Navigation Links
Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds
Date:5/23/2012

t this technological innovation has produced better long-term patient results. "It is reasonable to question whether the increased costs of this robotic-assisted approach are justified," said Dr. Nelson, who is also co-director of the University of Pittsburgh Cancer Institute's Prostate Cancer Program.

For their cost analysis, the researchers looked at the treatment of 473 consecutive patients from July 2009 to October 2010 at UPMC Shadyside hospital. Four urologic oncologists with considerable experience in RARP and RRP operated on these patients, using RARP for 115 and RRP for 358.

The overall cost per case for RARP exceeded the cost for RRP by almost $5,300. The major contributors to the cost gap were greater operating room supply costs and indirect costs associated with the purchase and maintenance of the robotic equipment. Operating room supply costs were almost seven times greater for RARP, while ancillary, cardiology, imaging, administrative, laboratory and pharmacy costs were not significantly different between the two approaches.

Several previous studies also have demonstrated a cost advantage for the standard open surgical approach. However, those studies sometimes excluded certain costs or involved hospitals with lower surgical volumes or surgeons who were less experienced with the robotic-assisted technology, potentially skewing the cost per case.

Dr. Nelson noted that randomized clinical trialsthe gold standard in scientific researchcomparing RRP and RARP are lacking. But a recent review of 37 comparative prostatectomy studies found no superiority for one approach vs. the other in terms of functional (such as post-operative continence and potency) and oncologic outcomes for patients.

"While further studies are needed to compare the long-term outcomes of RRP vs. RARP, our study suggests that our society may be paying too high a price for what has been widely perceived as a medical advance," said Dr. Nel
'/>"/>

Contact: Wendy Zellner
ZellnerWL@upmc.edu
412-586-9777
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers find anatomic differences after robotic-assisted radical prostatectomy
2. Prostate cancer patients treated with robotic-assisted surgery can expect low recurrence of cancer
3. Robotic-assisted vasectomy reversal offers greater chance of fatherhood
4. Psychological Science explains uproar over prostate-cancer screenings
5. Scientists unravel role of fusion gene in prostate cancer
6. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
7. Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk
8. Do Bald Men Face Higher Risk of Prostate Cancer?
9. Statins May Help Prevent Enlarged Prostate: Study
10. Scientists discover distinct molecular subtype of prostate cancer
11. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... PA (PRWEB) , ... July 30, 2015 , ... ... inventor from Texas, has designed a personal-care device that makes it easy to apply ... Buddy” could eliminate the need for assistance when applying lotion or medication to the ...
(Date:7/30/2015)... ... 2015 , ... 1Heart Caregiver Services LLC is offering its 1st Business Franchise ... the Booming Homecare Business.” This will be held in its main headquarters at 3600 ... will be hosted by 1Heart’s very own Randy Clarito (Director of Business and Franchise ...
(Date:7/30/2015)... ... 2015 , ... Political unrest is the number one concern ... survey by leading international insurance provider Clements Worldwide. The "Clements Worldwide Risk Index" ... largest sources of financial losses among respondents. , Twenty-eight percent of top managers ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Summer is ... hot spots.”* Add to that a particularly long, dry and hot 2015 summer season ... host and fresh water advocate Sharon Kleyne will discuss the 2015 summer season and ...
(Date:7/30/2015)... ... July 30, 2015 , ... WellSpan Health in ... (MAC) over submitted claims for bariatric surgery that, despite complying with national and ... Becky Dennis, a nurse auditor at WellSpan Health, tells Atlantic Information Services’ (AIS) ...
Breaking Medicine News(10 mins):Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 2Health News:Hospital Details Fight for Bariatric Surgery Reimbursement in AIS Newsletter 3
... 10 2007. A report to be published in an ... call for urgent attention to the politically sensitive issue of ... plans in the face of a catastrophic flu pandemic . ... transmission of a strain of avian influenza A (HN51) in ...
... Pharma US, Inc. today,announced results of an ... a prompt and sustained (over the 4-day,treatment ... among,hospitalized patients with euvolemic and hypervolemic hyponatremia ... correction. The study results were presented,during the ...
... in Council Bluffs, Now Offered to All Iowa ... ... Today, at the annual,conference of the Iowa State Police Association, ... Department,announced the availability of a community outreach program designed to,raise awareness ...
... Rat study suggests it boosts blood pressure, damages cells ... levels of lead exposure accelerated chronic kidney disease in ... kinds of cellular damage, U.S. researchers report. , Previous ... exposure and high blood pressure, atherosclerosis (hardening of the ...
... Gastrointestinal smooth muscle tumors (SMTs, including leiomyoma and ... to originate from a muscular layer of the ... esophagus, stomach, small intestine, and colon. SMTs are ... polyps, and complete surgical resection is still considered ...
... 10, 2007)--World Vaccine Congress: A first-in-man trial of a ... ADXS - News). The Phase I/II trial was testing ... is being developed by Advaxis as an immunotherapy that ... from human papilloma virus (HPV), including cervical cancer and ...
Cached Medicine News:Health News:Report highlights inadequate pandemic planning as a threat to EU security 2Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 2Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 3Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 4Health News:Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing Serum Sodium Levels in Patients With Euvolemic or Hypervolemic Hyponatremia 5Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 2Health News:Partnership for a Drug-Free America and Council Bluffs Police Department Introduce Methamphetamine Prevention Program to Iowa Law Enforcement 3Health News:Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released 2
(Date:7/30/2015)... , Net Sales of $1.17 billion represent ... and an increase of 5.7% constant currency , Reported ... and adjusted earnings per share were $1.59, an increase of ... guidance Zimmer Biomet Holdings, Inc. (NYSE and ... June 30, 2015.  The Company reported second quarter net sales ...
(Date:7/29/2015)... , July 30, 2015  Astellas today ... study evaluating the efficacy and safety of intravenous ... (isavuconazonium sulfate), under development for adults with candidemia ... from the study demonstrated that the trial did ... overall treatment response in isavuconazole-treated patients at the ...
(Date:7/29/2015)... 2015  Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 2015 on Wednesday, August 5, 2015, after the close of ... executive officer, will host a conference call to review the ... Time (PT). The press release and a ... through a link that is posted on the home page ...
Breaking Medicine Technology:Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 2Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 3Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 4Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 5Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 6Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 7Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 8Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 9Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 10Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 11Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 12Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 13Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 14Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 15Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 16Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 17Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 18Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 19Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 20Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 21Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 22Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 23Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 24Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 25Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 26Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 27Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 28Zimmer Biomet Holdings, Inc. Reports Second Quarter 2015 Financial Results 29Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3